AMAG Pharmaceuticals acquired Cord Blood Registry (CBR), the world’s largest umbilical cord blood stem cell collection and storage company serving pregnant women and their families, in August 2015. For more information, please visit www.cordblood.com.
GROWING: AMAG is focused on driving organic growth of its products in their indicated patient populations.
BUILDING: AMAG intends to expand its portfolio with additional specialty products that leverage the company’s strong foundation.
TOGETHER: We will develop and build AMAG’s organizational capabilities to support our planned growth and expansion.